Francisco Grandas

4.5k total citations
78 papers, 2.1k citations indexed

About

Francisco Grandas is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Francisco Grandas has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Neurology, 17 papers in Cellular and Molecular Neuroscience and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Francisco Grandas's work include Parkinson's Disease Mechanisms and Treatments (48 papers), Neurological disorders and treatments (42 papers) and Botulinum Toxin and Related Neurological Disorders (22 papers). Francisco Grandas is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (48 papers), Neurological disorders and treatments (42 papers) and Botulinum Toxin and Related Neurological Disorders (22 papers). Francisco Grandas collaborates with scholars based in Spain, United Kingdom and United States. Francisco Grandas's co-authors include Niall Quinn, C. D. Marsden, Masahiro Nomoto, Jonathan M. Brotchie, Giovanni Fabbrini, Christopher G. Goetz, John Elston, Ana Contreras, José Á. Obeso and César Tabernero and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Francisco Grandas

76 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Grandas Spain 22 1.7k 588 212 200 190 78 2.1k
Monika Rudzińska Poland 23 1.3k 0.8× 491 0.8× 157 0.7× 233 1.2× 86 0.5× 104 1.8k
Jinyoung Youn South Korea 25 1.1k 0.7× 385 0.7× 210 1.0× 233 1.2× 92 0.5× 132 1.9k
Jin Whan Cho South Korea 24 1.2k 0.7× 445 0.8× 168 0.8× 166 0.8× 77 0.4× 127 1.7k
Spyridon Konitsiotis Greece 21 928 0.6× 307 0.5× 179 0.8× 114 0.6× 128 0.7× 71 1.5k
Alberto Romagnolo Italy 27 1.3k 0.8× 307 0.5× 159 0.8× 116 0.6× 136 0.7× 78 1.8k
Ludwig Schelosky Germany 20 1.2k 0.7× 414 0.7× 215 1.0× 265 1.3× 67 0.4× 34 1.6k
Dagmar Verbaan Netherlands 29 2.3k 1.4× 358 0.6× 381 1.8× 227 1.1× 163 0.9× 93 3.1k
Ulrich Dillmann Germany 24 1.2k 0.7× 499 0.8× 164 0.8× 204 1.0× 104 0.5× 77 2.1k
Giovanni Mostile Italy 24 1.1k 0.6× 384 0.7× 162 0.8× 120 0.6× 51 0.3× 99 1.8k
M. Steiger United Kingdom 23 1.2k 0.7× 293 0.5× 290 1.4× 284 1.4× 45 0.2× 40 1.8k

Countries citing papers authored by Francisco Grandas

Since Specialization
Citations

This map shows the geographic impact of Francisco Grandas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Grandas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Grandas more than expected).

Fields of papers citing papers by Francisco Grandas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Grandas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Grandas. The network helps show where Francisco Grandas may publish in the future.

Co-authorship network of co-authors of Francisco Grandas

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Grandas. A scholar is included among the top collaborators of Francisco Grandas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Grandas. Francisco Grandas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Kris A., et al.. (2025). Detecting Postural Instability in Parkinson’s Disease From IMU-Based Objective Measures. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 33. 2044–2054.
2.
Navas‐Sánchez, Francisco J., Daniel Martín de Blas, Yasser Alemán‐Gómez, et al.. (2022). Tract-specific damage at spinal cord level in pure hereditary spastic paraplegia type 4: a diffusion tensor imaging study. Journal of Neurology. 269(6). 3189–3203. 3 indexed citations
3.
Casa‐Fages, Beatriz De la, et al.. (2021). Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors. Neurología. 38(9). 625–634. 12 indexed citations
4.
Navas‐Sánchez, Francisco J., Daniel Martín de Blas, Yasser Alemán‐Gómez, et al.. (2021). Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4. Journal of Neurology. 268(7). 2429–2440. 9 indexed citations
5.
Santos‐García, Diego, Marta Blázquez Estrada, Matilde Calopa, et al.. (2021). Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sciences. 11(8). 1027–1027. 9 indexed citations
6.
Valldeoriola, Francesc, Francisco Grandas, José Matías Arbelo, et al.. (2018). Consenso de expertos españoles sobre el uso de la safinamida en la enfermedad de Parkinson. Neurología. 36(9). 666–672. 6 indexed citations
7.
Cacheiro, Pilar, Andrés Ordóñez‐Ugalde, Beatriz Quintáns, et al.. (2017). Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants. Molecular Diagnosis & Therapy. 21(3). 303–313. 6 indexed citations
8.
Grandas, Francisco. (2013). Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson’s disease. Expert Review of Neurotherapeutics. 13(12). 1343–1353. 18 indexed citations
9.
Müller, Thomas, Teus van Laar, David R. Cornblath, et al.. (2013). Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery. Parkinsonism & Related Disorders. 19(5). 501–507. 94 indexed citations
10.
Contreras, Ana & Francisco Grandas. (2012). Risk factors for freezing of gait in Parkinson's disease. Journal of the Neurological Sciences. 320(1-2). 66–71. 47 indexed citations
11.
Steiger, M., Wolfgang H. Jost, Francisco Grandas, & Guy Van Camp. (2009). Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review. Journal of Neural Transmission. 116(2). 179–191. 29 indexed citations
12.
Fabbrini, Giovanni, Jonathan M. Brotchie, Francisco Grandas, Masahiro Nomoto, & Christopher G. Goetz. (2007). Levodopa‐induced dyskinesias. Movement Disorders. 22(10). 1379–1389. 354 indexed citations
13.
Grandas, Francisco. (2006). Levodopa for the Treatment of Parkinson’s Disease: Current Perspectives. Aging Health. 2(1). 101–109. 1 indexed citations
14.
Grandas, Francisco, et al.. (2004). Transient blepharospasm secondary to unilateral striatal infarction. Movement Disorders. 19(9). 1100–1102. 17 indexed citations
15.
Grandas, Francisco & Jaime Kulisevsky. (2002). Treatment of Parkinson's disease in Spain. Movement Disorders. 18(1). 87–89. 5 indexed citations
16.
Grandas, Francisco, M Galiano, & César Tabernero. (1999). Risk factors for levodopa-induced dyskinesias in Parkinson's disease. Journal of Neurology. 246(12). 1127–1133. 115 indexed citations
17.
Grandas, Francisco, et al.. (1998). Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxin.. PubMed. 21(5). 307–11. 24 indexed citations
18.
Grandas, Francisco. (1995). [Clinical application of botulinum toxin].. PubMed. 10(6). 224–33. 1 indexed citations
19.
Grandas, Francisco, Stephen T. Gancher, G. Lera, et al.. (1992). Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's disease. Neurology. 42(7). 1287–1287. 21 indexed citations
20.
Obeso, José Á., et al.. (1987). Continuous Dopaminergic Stimulation in Parkinson's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 488–492. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Rudzińska Breakdown of academic impact, for papers by Jinyoung Youn Breakdown of academic impact, for papers by Jin Whan Cho Breakdown of academic impact, for papers by Spyridon Konitsiotis Breakdown of academic impact, for papers by Alberto Romagnolo Breakdown of academic impact, for papers by Ludwig Schelosky Breakdown of academic impact, for papers by Dagmar Verbaan Breakdown of academic impact, for papers by Ulrich Dillmann Breakdown of academic impact, for papers by Giovanni Mostile Breakdown of academic impact, for papers by M. Steiger
Rankless by CCL
2026